Libtayo 350 MG/7 ML vial 7ML
Ended Awarded
- Contract number
- SPE2DR26F9BM2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,737
Award facts
- Contract value 100% obligated
- $13,737.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Libtayo 350 mg/7 mL vials, valued at $13,737.38 under a firm fixed-price contract type. This delivery order represents a non-competitive set-aside award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 5, 2025. Libtayo is a specialized pharmaceutical product used in cancer immunotherapy, reflecting the company's role as a critical vendor for federal medical procurement, particularly within military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's status as a prime pharmaceutical vendor demonstrates its established capability to meet federal procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9BM2?
SPE2DR26F9BM2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BM2 worth?
The government has obligated $13,737 on SPE2DR26F9BM2.
Is contract SPE2DR26F9BM2 an order under another contract?
Yes. SPE2DR26F9BM2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BM2 competed?
The extent of competition for SPE2DR26F9BM2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award